NO20006547L - Salter av paroxetine - Google Patents

Salter av paroxetine

Info

Publication number
NO20006547L
NO20006547L NO20006547A NO20006547A NO20006547L NO 20006547 L NO20006547 L NO 20006547L NO 20006547 A NO20006547 A NO 20006547A NO 20006547 A NO20006547 A NO 20006547A NO 20006547 L NO20006547 L NO 20006547L
Authority
NO
Norway
Prior art keywords
paroxetine
salts
therapy
processes
preparation
Prior art date
Application number
NO20006547A
Other languages
English (en)
Other versions
NO20006547D0 (no
Inventor
Victor Witold Jacewicz
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20006547D0 publication Critical patent/NO20006547D0/no
Publication of NO20006547L publication Critical patent/NO20006547L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Piperidin-forbindelser, fremgangsmåter for fremstilling av dem, farmasøytiske preparater omfattende dem og anvendelse av dem i terapi er beskrevet.
NO20006547A 1998-07-02 2000-12-21 Salter av paroxetine NO20006547L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine

Publications (2)

Publication Number Publication Date
NO20006547D0 NO20006547D0 (no) 2000-12-21
NO20006547L true NO20006547L (no) 2001-02-12

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006547A NO20006547L (no) 1998-07-02 2000-12-21 Salter av paroxetine

Country Status (21)

Country Link
EP (1) EP1091958A1 (no)
JP (1) JP2002519421A (no)
KR (1) KR20010053337A (no)
CN (1) CN1314906A (no)
AP (1) AP2000002017A0 (no)
AU (2) AU4903999A (no)
BG (1) BG105204A (no)
BR (1) BR9911679A (no)
CA (1) CA2336470A1 (no)
CZ (1) CZ20004923A3 (no)
EA (1) EA200100098A1 (no)
GB (1) GB9814316D0 (no)
HU (1) HUP0103712A3 (no)
ID (1) ID27766A (no)
IL (1) IL140385A0 (no)
NO (1) NO20006547L (no)
PL (1) PL345365A1 (no)
SK (1) SK20242000A3 (no)
TR (1) TR200100055T2 (no)
WO (1) WO2000001692A1 (no)
ZA (2) ZA992899B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
ES2393781T3 (es) 2003-05-07 2012-12-28 Osteologix A/S Combinaciones de estroncio para la profilaxis/tratamiento de afecciones de cartílagos y/o huesos
US20080167513A1 (en) 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
CN101010087B (zh) 2004-05-06 2012-06-27 奥斯泰奥洛吉斯公司 用于制备金属有机盐的高收率和快速的合成方法
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
ES2745411T3 (es) * 2006-07-27 2020-03-02 Wang Nai Fang Compuestos y composiciones de arilsulfanilo para administración de agentes activos
CN109212055B (zh) * 2018-08-19 2021-05-07 丁立平 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633B (zh) * 2018-11-27 2020-10-02 北京市化工职业病防治院 尿液中苯、甲苯和二甲苯代谢物的检测方法
CN111337460B (zh) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 一种高稳定性Halo-tag探针及其合成和生物应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
PT994872E (pt) * 1997-06-10 2001-09-28 Synthon Bv Composto de 4-fenilpiperidina
WO1999040084A1 (en) * 1998-02-06 1999-08-12 Smithkline Beecham Plc Salts of paroxetine

Also Published As

Publication number Publication date
ZA992899B (en) 2000-03-29
AP2000002017A0 (en) 2000-12-31
CZ20004923A3 (cs) 2001-08-15
EP1091958A1 (en) 2001-04-18
WO2000001692A1 (en) 2000-01-13
AU4903999A (en) 2000-01-24
GB9814316D0 (en) 1998-09-02
ID27766A (id) 2001-04-26
BR9911679A (pt) 2002-01-29
IL140385A0 (en) 2002-02-10
PL345365A1 (en) 2001-12-17
KR20010053337A (ko) 2001-06-25
JP2002519421A (ja) 2002-07-02
SK20242000A3 (sk) 2001-07-10
AU2002100370A4 (en) 2002-06-06
CN1314906A (zh) 2001-09-26
TR200100055T2 (tr) 2001-07-23
CA2336470A1 (en) 2000-01-13
EA200100098A1 (ru) 2001-08-27
NO20006547D0 (no) 2000-12-21
ZA200100020B (en) 2002-03-25
HUP0103712A2 (hu) 2002-05-29
BG105204A (en) 2001-11-30
HUP0103712A3 (en) 2002-09-30

Similar Documents

Publication Publication Date Title
ES2158778A1 (es) Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen.
BR0016543A (pt) Novos derivados de piperidina e piperazina
NO20002787L (no) Nye forbindelser
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
NO20075066L (no) Farmasoytisk sammensetning som inneholder isoflavoner
SE9904505D0 (sv) Novel compounds
NO20006521L (no) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivater
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
MXPA02011304A (es) Derivados de piperidina farmaceuticamente activos, en partiular como moduladores de la actividad del receptor de la quimocina.
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
NO20051966L (no) Nye pyrimidinamidderivater og anvendelse derav
SE9900961D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
NO20020282D0 (no) Nytt difenylpiperidinderivat
BR0213994A (pt) Derivados heterocìclicos de glicinamida e seus usos médicos
NO20006547L (no) Salter av paroxetine
NO20001934L (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO20026081L (no) Nye forbindelser
SE9802209D0 (sv) Novel compounds
NO982863L (no) Nye forbindelser med analgetisk effekt
DE69813263T2 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
DK1150970T3 (da) (1-phenacy-3-phenyl-3-piperidylethyl)piperidin-derivater, fremgangsmåde til deres fremstilling og farmaceutiske sammensætningner indeholdende dem
JO2199B1 (en) Replaced pyrrols
SE9803107D0 (sv) Novel Compunds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application